Impact of<i>Lycium barbarum</i>arabinogalactan on the fecal metabolome in a DSS-induced chronic colitis mouse model
Cui Cao, Linlin Wang, Chunqing Ai, Guiping Gong, Zhongfu Wang, Linjuan Huang, Shuang Song, Beiwei Zhu
Abstract
Gut microbes and untargeted/targeted metabolomics were combined to comprehensively understand the therapeutic effect and the underlying mechanism of Lycium barbarum arabinogalactan (LBP-3) in DSS-induced colitis mice.
Topics & Concepts
LyciumMetabolomeArabinogalactanColitisMetabolomicsFecesChemistryMedicineBiologyMicrobiologyPolysaccharideImmunologyBioinformaticsBiochemistryPathologyAlternative medicinePolysaccharides and Plant Cell WallsGut microbiota and healthPharmacological Effects of Natural Compounds